Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and nonprofits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages ...
Aug 10, 2021
0
54
When so much time and effort goes into developing the best medical treatments, we expect them to be available when we need them. The same goes for addiction treatments, so it's worrying that two of the most effective drugs ...
May 5, 2023
0
3
Costs for epilepsy medications in the United States are skyrocketing, outpacing inflation and straining federal insurers Medicare and Medicaid, according to new research.
Dec 2, 2022
0
8
(HealthDay)—Rising drug spending in the United States is being fueled by expensive name-brand prescription medicines, a new study shows.
Nov 16, 2018
0
0
A new study out of Brigham and Women's Hospital shows how newly marketed brand-name drugs in the U.S. are driving up health care spending, resulting in "detrimental effects for patient access and affordability."
Jun 8, 2022
0
1
A simple shift in a vowel's sound can change the way people think and make decisions about objects – leading to a greater connection between a brand's name and product features a business wants to highlight, says new research ...
Jan 17, 2014
0
0
Prescription drug prices in the United States are significantly higher than in other nations, with prices in the U.S. averaging 2.56 times those seen in 32 other nations, according to a new RAND Corporation report.
Jan 28, 2021
0
6
Prescribing generic medications for heart and blood vessel diseases more frequently instead of brand-name medications in Medicare's prescription drug program, called Part D, could save more than $600 million each year in ...
Dec 9, 2021
0
9
Finland is seeking to tighten its already tough restrictions on public smoking and tobacco advertising in the next few years, in line with the national goal to phase out the habit almost completely by 2030.
Apr 27, 2021
0
3
Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in CMAJ (Canadian Medical Association Journal).
Nov 11, 2019
0
1
